St. Jude Medical Inc. (STJ)
-NYSE 45.15 
0.02(0.04%) May 24, 4:03PM EDT|After Hours
:
45.18 0.03 (0.06%) May 24, 4:54PM EDT
| Prev Close: | 45.17 |
|---|
| Open: | 44.86 |
|---|
| Bid: | 44.52 x 200 |
|---|
| Ask: | 49.82 x 700 |
|---|
| 1y Target Est: | 45.78 |
|---|
| Beta: | 1.3 |
|---|
| Next Earnings Date: | 15-Jul-13 |
|---|
| Day's Range: | 44.60 - 45.44 |
|---|
| 52wk Range: | 30.25 - 47.45 |
|---|
| Volume: | 1,085,301 |
|---|
| Avg Vol (3m): | 2,434,500 |
|---|
| Market Cap: | 12.79B |
|---|
| P/E (ttm): | 18.16 |
|---|
| EPS (ttm): | 2.49 |
|---|
| Div & Yield: | 1.00 (2.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- St. Jude Begins EnligHTNment StudyZacks(Fri, May 24)
- St Jude Medical Inc. (STJ): Today's Featured Health Services Laggardat TheStreet(Thu, May 23)
- CTRX, STJ, CI, TMO And BAX, Pushing Health Services Industry Downwardat TheStreet(Thu, May 23)
- St Jude Medical Inc. Stock Buy Recommendation Reiterated (STJ)at TheStreet(Thu, May 23)
- Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit Growth Ratesat Seeking Alpha(Thu, May 23)
- InPlay: St. Jude Medical one year data from study demonstrates safe, rapid and sustained blood pressure reduction with EnligHTN Renal Denervation TechnologyBriefing.com(Thu, May 23)
- One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation TechnologyBusiness Wire(Thu, May 23)
- Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargainat Investopedia(Wed, May 22)
- Medtronic Beats Earnings, Results StrongerZacks(Wed, May 22)
- What's Behind Medtronic's 5% Pop?at Motley Fool(Tue, May 21)
- Athletes With Defibrillators Don't Need To Quit Sportsat Forbes(Tue, May 21)
- St Jude Medical Reaches New 52-Week High (STJ)at TheStreet(Tue, May 21)
- St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice SessionBusiness Wire(Tue, May 21)
- Medtronic’s Heart Rhythm Devices Show Signs of Growthat Bloomberg(Tue, May 21)
- St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care ConferenceBusiness Wire(Tue, May 21)
Key Statistics
| Forward P/E (1 yr): | 11.49 |
|---|
| P/S (ttm): | 2.35 |
|---|
| Ex-Dividend Date: | 26-Jun-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.70 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.94 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.28 |
|---|
Business Summary
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems.
View More